Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000200406-26-000042
Filing Date
2026-02-18
Accepted
2026-02-18 21:12:20
Documents
1
Period of Report
2026-02-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1771467137.html 4  
1 FORM 4 wk-form4_1771467137.xml 4 27047
  Complete submission text file 0000200406-26-000042.txt   28458
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Issuer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1228
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Business Address
Mulholland Kristen (Reporting) CIK: 0002037288 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-03215 | Film No.: 26651285